Ophthalmic patients on antithrombotic drugs: a review and guide to perioperative management.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25425711.
- Also identified by DOI 10.1136/bjophthalmol-2014-306036.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The changing profile of patients undergoing ophthalmic surgery, with an increase in prevalence of antiplatelet and anticoagulant drug use, predisposes to bleeding complications. This mandates an awareness of these agents, allowing optimal patient management. We review traditional and newer agents in the context of cataract, vitreoretinal, glaucoma and oculoplastic surgery. Recommendations are given for continuation, cessation and re-commencement of these agents in order to minimise the risk of bleeding and thrombotic/thromboembolic complications.
Medical subject headings
- Anticoagulants
- Eye Hemorrhage
- Fibrinolytic Agents
- Ophthalmologic Surgical Procedures
- Perioperative Care
- Platelet Aggregation Inhibitors
- Postoperative Hemorrhage